Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rachel Mcminn Insider Profile
11 Followers
Rachel Mcminn, CSO at Intercept Pharma, holds 1.30M shares in Neurogene (Ticker: NGNE), holds 7.62K shares in Intercept Pharma (Ticker: ICPT). Most recently, Rachel Mcminn Bought ― shares of Neurogene on Nov 25, 2024 for an estimated value of 969.00K.
Profitable Transactions
15 out of 17 Profitable Transactions
Average Return
+22.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Rachel Mcminn holds in companies
Most Profitable Insider Trade
Stock:
Intercept Pharma
(ICPT)
(ICPT)
Rating:Informative Sell
Date:Nov 04, 2015 - Nov 04, 2016
Return:+47.00%
The most profitable trade made by Rachel Mcminn
Rachel Mcminn's Trading History
Intercept Pharma
Oct 04, 2017
―
Informative Sell
16.67K
$144.80K
Neurogene
Nov 25, 2024
CEO, Director
Informative Buy
969.00K
$29.38M
List of latest transactions for each holding click on a transaction to see Rachel Mcminn's performance on stock
You May Also Like
Rachel Mcminn insider profile FAQ
What is the percentage of profitable transactions made by Rachel Mcminn?
The percentage of profitable transactions made by Rachel Mcminn is 88%.
What is the average return per transaction made by Rachel Mcminn?
The average return per transaction made by Rachel Mcminn is 22.80%.
What stocks does Rachel Mcminn hold?
Rachel Mcminn holds: ICPT, NGNE stocks.
What was Rachel Mcminn’s latest transaction?
Rachel Mcminn latest transaction was an Informative Buy of $969.00K.
What was Rachel Mcminn's most profitable transaction?
Rachel Mcminn’s most profitable transaction was an Informative Sell of ICPT stock on November 4, 2015. The return on the trade was 47.00%.
What is Rachel Mcminn's role in Intercept Pharma?
Rachel Mcminn's role in Intercept Pharma is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.